Ocuphire Pharma Inc Stock Ownership - Who owns Ocuphire Pharma?

Insider buying vs selling

Have Ocuphire Pharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when OCUP insiders and whales buy or sell their stock.

OCUP Shareholders

What type of owners hold Ocuphire Pharma Inc stock?
Sungkee Chung779.70%163,800,000$548.73MInsider
Sung Sook Park334.16%70,200,000$235.17MInsider
Frank Ferraro123.76%26,000,000$87.10MInsider
Inok Ahn66.64%14,000,000$46.90MInsider
Chang Ho Ahn54.79%11,510,000$38.56MInsider
Rexgene Biotech Co Ltd26.21%5,505,956$18.44MInsider
Young Soon Park12.88%2,706,500$9.07MInsider
Vanguard Group Inc4.22%885,878$2.97MInstitution
Rice Hall James Associates LLC4.04%849,286$2.85MInstitution
Mina Sooch2.53%530,501$1.78MInsider

1 of 3

OCUP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAPR7.65%92.35%Net BuyingNet Buying
TSBX0.00%61.71%Net BuyingNet Buying
BCAB65.96%32.20%Net SellingNet Selling

Ocuphire Pharma Stock Ownership FAQ

Who owns Ocuphire Pharma?

Ocuphire Pharma (NASDAQ: OCUP) is owned by 17.50% institutional shareholders, 1,412.26% Ocuphire Pharma insiders, and 0.00% retail investors. Sungkee Chung is the largest individual Ocuphire Pharma shareholder, owning 163.80M shares representing 779.70% of the company. Sungkee Chung's Ocuphire Pharma shares are currently valued at $596.23M.

If you're new to stock investing, here's how to buy Ocuphire Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.